National Capital Area Chapter

Browse chapters by location

The Word:


PhRMA Recognized as 2013 "Titan of Business & Philanthropy" At the Annual Leukemia Ball

The Leukemia & Lymphoma Society (LLS) today announced they will honor the Pharmaceutical Research and Manufacturers of America (PhRMA) as a Titan of Business & Philanthropy at the 2013 Leukemia Ball.  The Titans of Business & Philanthropy program recognizes individuals or companies making an extraordinary difference in the community. Helping individuals live longer, healthier lives, PhRMA is a leader in their industry, with member companies investing over $500 billion in the search for new treatments and cures since 2000, including an estimated $49.5 billion in 2011 alone.

"PhRMA is honored to continue its long-standing support of The Leukemia & Lymphoma Society, a leader in the search for blood cancer cures," said John J. Castellani, PhRMA President and CEO.  "Our shared goal in discovering new technologies and treatment options has created an extraordinary partnership in the fight against cancer.  PhRMA, which represents the leading biopharmaceutical research companies, is committed to the development of the life-saving and life-enhancing medicines for patients." 

"The innovative research supported by PhRMA member companies is changing the landscape of cancer treatment, and in turn, helping LLS achieve its mission," said James H. Davis, Leukemia Ball Sr. co-Chair. "Their commitment to helping patients live longer, healthier lives, is one that we at LLS share, and we are thankful to them for their support and partnership."

The Leukemia Ball will take place on Saturday, March 23, 2013 at the Walter E. Washington Convention Center, with entertainment by Dana Carvey, and Jim Belushi and the Sacred Heart Band. The event is expected to raise $3.1 million for LLS's mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma and improve the quality of life of patients and their families. Sponsorship opportunities are available at a variety of levels. For more information visit

last updated on Wednesday, February 27, 2013